Driving Transformation in African Healthcare

i3, a pan-African initiative dedicated to scaling health-tech startups, announced four significant partnerships at its fourth annual Access to Markets (A2M) event. These deals represent a major boost for healthcare innovation across the continent, addressing critical needs from chronic disease management to pharmaceutical safety.

The A2M event serves as a vital platform connecting promising e-health companies with strategic partners—and this year’s edition delivered transformative outcomes. The new partnerships will focus on:

• Expanding access to affordable medicines: Meditect secured debt financing from Boehringer Ingelheim to expand its reach across Sub-Saharan Africa
• Strengthening pharmacy regulation: Sproxil and the Pharmacy Council of Nigeria (PCN) joined forces using digital and AI solutions
• Improving chronic disease care: MYDAWA partnered with Endless Health to co-design a digital model for hypertension and diabetes management
• Financial support for healthcare providers: Dawa Mkononi and NMB Bank created an interest-free credit facility for pharmacies and health facilities in Tanzania

A Proven Track Record of Impact

i3 has already facilitated over 760 bespoke introductions, leading to 165 partnerships valued at more than US$19 million. Its innovators have served millions of patients and tracked the distribution of hundreds of millions of health products—demonstrating a tangible impact on access to care and safe medicines across Africa.

The initiative is funded by the Bill & Melinda Gates Foundation and supported by leading organizations like MSD, Cencora, Endless Foundation, HELP Logistics, Sanofi’s Global Health Unit, and Chemonics. With these new deals, i3 continues to fulfill its mission of accelerating healthcare innovation for a healthier Africa.